BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33430890)

  • 1. PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.
    Videira A; Beckedorff FC; daSilva LF; Verjovski-Almeida S
    Cell Commun Signal; 2021 Jan; 19(1):5. PubMed ID: 33430890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.
    Wu L; Runkle C; Jin HJ; Yu J; Li J; Yang X; Kuzel T; Lee C; Yu J
    Oncogene; 2014 Jan; 33(4):504-13. PubMed ID: 23318417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
    Bohrer LR; Chen S; Hallstrom TC; Huang H
    Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.
    Guo J; Wei Z; Jia T; Wang L; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Wang K; Fu B; Chen SS
    J Transl Med; 2023 Oct; 21(1):716. PubMed ID: 37828515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin Landscape Distinguishes the Genomic Loci of Hundreds of Androgen-Receptor-Associated LincRNAs From the Loci of Non-associated LincRNAs.
    daSilva LF; Beckedorff FC; Ayupe AC; Amaral MS; Mesel V; Videira A; Reis EM; Setubal JC; Verjovski-Almeida S
    Front Genet; 2018; 9():132. PubMed ID: 29875794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator.
    Kim J; Lee Y; Lu X; Song B; Fong KW; Cao Q; Licht JD; Zhao JC; Yu J
    Cell Rep; 2018 Dec; 25(10):2808-2820.e4. PubMed ID: 30517868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
    Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
    Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.
    Long MD; Singh PK; Russell JR; Llimos G; Rosario S; Rizvi A; van den Berg PR; Kirk J; Sucheston-Campbell LE; Smiraglia DJ; Campbell MJ
    Oncogene; 2019 Jan; 38(3):421-444. PubMed ID: 30120411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.
    Levina E; Ji H; Chen M; Baig M; Oliver D; Ohouo P; Lim CU; Schools G; Carmack S; Ding Y; Broude EV; Roninson IB; Buttyan R; Shtutman M
    Oncotarget; 2015 May; 6(15):13088-104. PubMed ID: 26036626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of androgen response-related lncRNAs in prostate cancer.
    Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S
    Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.
    Sakurai K; Reon BJ; Anaya J; Dutta A
    Mol Cancer Res; 2015 May; 13(5):828-38. PubMed ID: 25700553
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Nylund P; Garrido-Zabala B; Párraga AA; Vasquez L; Pyl PT; Harinck GM; Ma A; Jin J; Öberg F; Kalushkova A; Wiklund HJ
    Haematologica; 2024 Feb; 109(2):567-577. PubMed ID: 37496441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer.
    Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Urano T; Takahashi S; Homma Y; Aburatani H; Inoue S
    Oncotarget; 2015 Feb; 6(4):2263-76. PubMed ID: 25537508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.
    Mukhopadhyay NK; Kim J; You S; Morello M; Hager MH; Huang WC; Ramachandran A; Yang J; Cinar B; Rubin MA; Adam RM; Oesterreich S; Di Vizio D; Freeman MR
    Oncogene; 2014 Jun; 33(25):3235-45. PubMed ID: 23893242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
    Beke L; Nuytten M; Van Eynde A; Beullens M; Bollen M
    Oncogene; 2007 Jul; 26(31):4590-5. PubMed ID: 17237810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2.
    Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B
    Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
    Weber H; Ruoff R; Garabedian MJ
    PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.